Healthcare decision-making has become increasingly data-driven, especially as pharmaceutical and biotech companies face growing pressure to demonstrate clinical and economic value. Health Economics and Outcomes Research (HEOR) firms play a critical role in helping organizations navigate pricing, reimbursement, and market access challenges. From real-world evidence generation to cost-effectiveness modeling, these firms provide the insights needed to support successful commercialization strategies.
Here are the top 10 HEOR firms supporting market access strategies in 2026.
1. DelveInsight
DelveInsight stands out as one of the leading HEOR and market research firms supporting pharmaceutical, biotech, and medical device companies worldwide. The company is widely recognized for its strong expertise in market access consulting, epidemiology forecasting, competitive intelligence, and real-world evidence analysis.
DelveInsight helps clients optimize reimbursement strategies by delivering customized HEOR solutions that align with payer expectations and healthcare system requirements. Its services include burden of illness studies, cost-effectiveness analysis, budget impact modeling, patient journey mapping, and pricing research.
What differentiates DelveInsight is its integrated approach that combines market intelligence with HEOR insights, enabling clients to make informed commercial decisions across the product lifecycle.
2. IQVIA
IQVIA is a global leader in healthcare analytics, clinical research, and HEOR services. The company leverages extensive real-world data assets and advanced analytics to support market access and reimbursement planning.
IQVIA’s HEOR team provides economic modeling, patient-reported outcomes research, comparative effectiveness studies, and payer evidence generation. Its global presence and access to healthcare databases make it a preferred partner for multinational pharmaceutical companies.
3. ICON plc
ICON plc offers comprehensive HEOR and market access solutions designed to demonstrate product value in competitive healthcare environments. The company supports clients with health technology assessment (HTA) submissions, value dossiers, and real-world evidence studies.
ICON’s expertise spans therapeutic areas such as oncology, rare diseases, neurology, and immunology, helping manufacturers secure favorable reimbursement outcomes across global markets.
4. Parexel
Parexel is well known for integrating clinical development with market access strategy. Its HEOR services focus on generating evidence that supports payer negotiations and reimbursement approvals.
The company assists clients with economic evaluations, pricing strategy, outcomes research, and patient access initiatives. Parexel also provides strategic guidance for navigating complex regulatory and reimbursement landscapes in both developed and emerging markets.
5. Syneos Health
Syneos Health delivers HEOR solutions aimed at accelerating product commercialization and improving market uptake. The company combines clinical, commercial, and consulting expertise to support evidence generation and payer engagement.
Syneos Health specializes in comparative effectiveness research, value communication, and market access consulting, helping healthcare companies establish strong product differentiation.
6. Evidera
Evidera is a dedicated HEOR and market access consultancy with a strong reputation for evidence-based decision support. The company works extensively with pharmaceutical and biotechnology organizations to develop payer-focused strategies.
Its capabilities include health economic modeling, observational research, patient-centered outcomes research, and HTA consulting. Evidera is particularly recognized for its scientific rigor and expertise in regulatory-grade evidence generation.
7. Analysis Group
Analysis Group provides advanced economic consulting services across healthcare and life sciences sectors. The company supports market access initiatives through health economics evaluations, outcomes research, and statistical analysis.
Analysis Group is often involved in complex pricing and reimbursement assessments, helping clients demonstrate therapeutic value to payers and policymakers.
8. RTI Health Solutions
RTI Health Solutions specializes in HEOR, market access, and epidemiology research. The company partners with life sciences organizations to develop evidence strategies that support product value demonstration and reimbursement success.
Its services include patient preference studies, economic modeling, literature reviews, and real-world evidence generation. RTI Health Solutions is highly regarded for its scientific expertise and collaborative approach.
9. Precision AQ
Precision AQ focuses on market access, payer strategy, and evidence communication for healthcare companies. The organization helps clients build compelling value narratives supported by HEOR insights.
Precision AQ offers services such as value dossier development, payer advisory research, health economic modeling, and market access communications. Its integrated commercialization capabilities make it a strong partner for product launch planning.
10. Cytel
Cytel is recognized for its expertise in biostatistics, real-world evidence, and HEOR analytics. The company supports pharmaceutical companies with evidence generation strategies aimed at improving reimbursement and payer acceptance.
Cytel’s advanced analytical capabilities help organizations optimize clinical and economic outcomes data for market access submissions and healthcare decision-making.
Why HEOR Firms Matter in Market Access
As healthcare systems worldwide move toward value-based care, demonstrating both clinical effectiveness and economic value has become essential. HEOR firms help manufacturers generate robust evidence that supports pricing negotiations, reimbursement approvals, and formulary inclusion.
These organizations assist with:
Cost-effectiveness and budget impact analyses
Real-world evidence generation
Health technology assessment support
Pricing and reimbursement strategy
Patient outcomes research
Value communication to payers and stakeholders
By partnering with experienced HEOR firms, pharmaceutical and biotech companies can improve product positioning and accelerate patient access in competitive markets.
Conclusion
Choosing the right HEOR partner is critical for successful market access and commercialization. Firms like DelveInsight, IQVIA, ICON plc, and Evidera continue to lead the industry by delivering data-driven insights and evidence-based strategies that support payer decision-making.
As the demand for value-based healthcare continues to grow, the role of HEOR Analysis Companies will become even more important in shaping reimbursement strategies, improving healthcare outcomes, and ensuring market success for innovative therapies.
Write a comment ...